Do long-term side effects matter? Evaluating the risk of hip fracture in subjects with schizophrenia over a decade.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2015-09-23

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.14com09557PMID 26455691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.

  2015cited by this paper
• Assessment and management of fracture risk in patients with Parkinson's disease.

  2015cited by this paper
• Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

  2013cited by this paper
• A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia

  2012cited by this paper
• Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study

  2009cited by this paper
• Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women

  2008cited by this paper
• Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study.

  2007cited by this paper
• Risk of hip/femur fractures in patients using antipsychotics.

  2005cited by this paper
• Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.

  2004cited by this paper

• Bipolar disorder and the risk of fracture: A nationwide population-based cohort study.

  2017cites this paper